- Home
- PGEN vs CCEC Comparison
PGEN vs CCEC Comparison
Compare PGEN & CCEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PGEN | CCEC |
|---|---|---|
| Founded | 1998 | 2007 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | PGEN | CCEC |
|---|---|---|
| Price | $3.76 | $20.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $7.67 | ★ $26.00 |
| AVG Volume (30 Days) | ★ 4.8M | 12.9K |
| Earning Date | 11-13-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 2.99% |
| EPS Growth | N/A | ★ 304.00 |
| EPS | N/A | ★ 4.79 |
| Revenue | $6,309,000.00 | ★ $421,795,000.00 |
| Revenue This Year | $249.10 | $16.66 |
| Revenue Next Year | $710.03 | $14.48 |
| P/E Ratio | ★ N/A | $8.00 |
| Revenue Growth | ★ 59.20 | 32.74 |
| 52 Week Low | $0.65 | $14.09 |
| 52 Week High | $5.23 | $24.83 |
Technical Indicators
Market Signals| Indicator | PGEN | CCEC |
|---|---|---|
| Relative Strength Index (RSI) | 45.01 | 47.61 |
| Support Level | $3.54 | $18.56 |
| Resistance Level | $5.19 | $20.45 |
| Average True Range (ATR) | 0.39 | 0.96 |
| MACD | -0.09 | 0.04 |
| Stochastic Oscillator | 13.03 | 55.06 |
Price Performance
Historical ComparisonAbout PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About CCEC Capital Clean Energy Carriers Corp. Common Share
Capital Clean Energy Carriers Corp is an international shipping company. It is the platform of gas carriage solutions with a focus on the energy transition. The company owns 20 high-specification vessels, including 12 latest-generation LNG carriers (LNG/Cs) and eight legacy Neo-Panamax container vessels.